Search Results - "Awasthi, Anshumali"
-
1
Oral Bioavailability Enhancement of Exemestane from Self-Microemulsifying Drug Delivery System (SMEDDS)
Published in AAPS PharmSciTech (2009)“…Limited aqueous solubility of exemestane leads to high variability in absorption after oral administration. To improve the solubility and bioavailability of…”
Get full text
Journal Article -
2
Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: Application to pharmacokinetic studies
Published in Talanta (Oxford) (15-09-2008)“…A new, simple, sensitive and specific reversed-phase high performance liquid chromatographic (HPLC) method using ultraviolet detection was developed and…”
Get full text
Journal Article -
3
Evaluation of herb-drug interaction of a polyherbal Ayurvedic formulation through high throughput cytochrome P450 enzyme inhibition assay
Published in Journal of ethnopharmacology (02-02-2017)“…Arishtas are Ayurvedic formulation made with decoction of herbs. Arjunarishta formulation is being used in Ayurveda for cardio-protective activity…”
Get full text
Journal Article -
4
Antidiabetic potential of polyherbal formulation DB14201: Preclinical development, safety and efficacy studies
Published in Journal of ethnopharmacology (02-02-2017)“…The poly-herbal formulation DB14201 is a new combination of ayurvedic ingredients for treatment of diabetes. The aim of present study was to investigate safety…”
Get full text
Journal Article -
5
Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: Possible contribution of P-glycoprotein
Published in Life sciences (1973) (15-08-2008)“…P-glycoprotein (P-gp) is found to play a very significant role in intestinal and biliary transport of irinotecan and its active metabolite, SN-38. This makes…”
Get full text
Journal Article -
6
Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent
Published in Cancer chemotherapy and pharmacology (01-11-2007)“…Noscapine, a naturally occurring antitussive phthalideisoquinoline alkaloid, is a tubulin-binding agent currently in Phase I/II clinical trials for anticancer…”
Get full text
Journal Article -
7
Pharmacokinetic evaluation of C-3 modified 1,8-naphthyridine-3-carboxamide derivatives with potent anticancer activity: lead finding
Published in Journal of enzyme inhibition and medicinal chemistry (01-10-2014)“…To develop naphthyridine derivatives as anticancer candidates, pharmacokinetic (PK) evaluations of 10 novel derivatives of…”
Get more information
Journal Article -
8
Cellular mechanisms mediating the anticancer activity of a novel polyherbal formulation
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
9
Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel(TM)
Published in Clinical & translational oncology (01-01-2013)“…An increasing research interest has been directed toward nanoparticle-based drug delivery systems for their advantages. The appropriate amalgamation of pH…”
Get full text
Journal Article -
10
High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats
Published in Talanta (Oxford) (15-06-2009)“…Bicalutamide is a non-steroidal antiandrogen and is an oral medication that is used for treating prostate cancer. To evaluate the bioavailability of…”
Get full text
Journal Article -
11
Non‐toxic melanoma therapy by a novel tubulin‐binding agent
Published in International journal of cancer (01-01-2010)“…(S)‐3‐((R)‐9‐bromo‐4‐methoxy‐6‐methyl‐5,6,7,8‐tetrahydro‐[1,3]dioxolo[4,5‐g]isoquino‐lin‐5‐yl)‐6,7‐dimethoxyisobenzofuran‐1(3H)‐one (EM011) is a…”
Get full text
Journal Article -
12
Application of a liquid chromatography-electrospray mass spectrometry (LC/MS) method to the biodistribution and excretion studies of novel 5′-chloro-2, 3-didehydroindolo (2′, 3′: 2, 3) betulinic acid (DRF-4012) in tumour-bearing mice
Published in Xenobiotica (01-06-2013)“…Novel betulinic acid derivative 5′-chloro-2, 3-didehydroindolo [2′, 3′: 2, 3] betulinic acid (DRF-4012) is a new effective lupane type triterpenes with greater…”
Get full text
Journal Article -
13
Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, NanoxelTM
Published in Clinical & translational oncology (2013)“…Introduction An increasing research interest has been directed toward nanoparticle-based drug delivery systems for their advantages. The appropriate…”
Get full text
Journal Article -
14
LC-UV Detection of 5′-Chloro-2,3-didehydroindolo[2′,3′:2,3]betulinic Acid in Rat Plasma and Its Application to a Pharmacokinetic Study
Published in Chromatographia (01-02-2011)“…A simple, rapid and sensitive high-performance liquid chromatography LC (HPLC) method of determining the concentration of the novel betulinic acid derivative…”
Get full text
Journal Article -
15
Evaluation of in vitro Anti-psoriatic Activity of a Novel Polyherbal Formulation by Multiparametric Analysis
Published in Anti-inflammatory & anti-allergy agents in medicinal chemistry (2017)“…We have developed a novel aqueous polyherbal formulation (SIRB-001) consisting of 3 herbs; Rheum palmatum L., Lonicera Japonica and Rehmannia glutinosa Libosch…”
Get more information
Journal Article